He died of a drug overdose in August 1966 ... Detailing the author’s own experience of taking mescaline, it chimed with the consciousness-expanding ethos of the decade, and even gave The ...

mescaline—and DMT. For so many years of his career as a drug dealer, he’d been told the medicine was protected by a higher power. Now, with a kind of uncanny timing, it actually was.

Here's how the 2025 depth chart shapes up at this point, with perhaps a couple more free agency additions still on the horizon: The Ravens considered drafting another developmental backup ...

The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to induce neurologic side effects compared with typical (conventional) antipsychotics ...

The drug, called trontinemab, showed in the study that it could achieve rapid and deep reductions in amyloid beta plaques in the brain, one of the characteristics of Alzheimer's. Roche said its ...

Vyloy is the first CLDN18.2-targeting drug to reach the US market but has already been approved in Japan as well as in the EU and GB. Astellas refiled its marketing application in May, and the FDA ...

Mullein is not approved by the Food and Drug Administration (FDA) to treat any health condition. Some people suggest it may relieve asthma, which causes your airway to swell and results in ...

Ultrafine particle meter-dose inhalers (MDIs) have not demonstrated superior asthma control or improved safety over older MDIs. All of the inhaled corticosteroids demonstrate efficacy with once ...

In a randomized, double-blind, placebo-controlled study by Palhano-Fontes et al. (2019), a single dose of ayahuasca was administered to 29 patients with treatment-resistant depression. A significant ...